Results 101 to 110 of about 5,545,002 (288)
Background Glycated hemoglobin (HbA1c) is accepted as the most reliable marker for assessing chronic glycemia. The present study aimed to investigate glycemic control in cardiovascular outcome trials (CVOTs) performed by pharmaceutical sponsors, at the ...
Rumiko Shimazawa, Masayuki Ikeda
doaj +1 more source
Abstract not availableBangladesh Pharmaceutical Journal 18(1): 83-84 ...
openaire +3 more sources
The US Food and Drug Administration’s expedited approval programs: addressing premarket flexibility with enhanced postmarket evidence generation [PDF]
When the editors of Clinical Trials solicited our review on the U.S. Food and Drug Administration’s (FDA) expedited development and review programs, we anticipated there would be accompanying commentaries from other academics with differing opinions, or ...
Naci, Huseyin +2 more
core +1 more source
Maximizing the Impact of Microphysiological Systems with in Vitro–in Vivo Translation [PDF]
Microphysiological systems (MPS) hold promise for improving therapeutic drug approval rates by providing more physiological, human-based, in vitro assays for preclinical drug development activities compared to traditional in vitro and animal models. Here,
Cirit, Murat, Stokes, Cynthia L.
core +1 more source
Fluoroquinolones and tendon disorders [PDF]
Since the 'thalidomide disaster' in 1961, there is extensive national and intemationallegisiation for the registration and monitoring of drugs. The current drug approval process in most developed countries includes pre-clinical animal testing followed
Linden, P.D. (Paul) van der
core +1 more source
Several malignant disorders of human tissues affect a large proportion of people in Colombia and worldwide, which has led to an increase in pharmacological treatments for these diseases, without the real benefit being clear to the patients who receive ...
Arango Vélez, Elkin Fernando +7 more
doaj +1 more source
Regulation with Placebo Effects [PDF]
A growing scientific literature supports the existence of placebo effects from a wide range of health interventions and for a range of medical conditions.
Malani, Anup
core +1 more source
The Drug Approval Process in the U.S., Europe, and Japan [PDF]
Ines Vilas-Boas
openalex +1 more source

